Walleye Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$477K Sell
2024
Q4
$1.78M Buy
2023
Q4
Sell
2023
Q3
$794K Sell
2023
Q2
$3.54M Buy
2023
Q1
$954K Sell
2022
Q4
$6.6M Buy
2022
Q3
$4.25M Buy
2022
Q1
Sell
2021
Q4
$150K Buy
2019
Q3
Sell
2019
Q2
$120K Buy